There could be an upside to incorporating AI for the FDA. Using AI to assist in final drug reviews would "represent a chance ...

The Food and Drug Administration is going all in on artificial intelligence. | The Food and Drug Administration is going all ...

The Food and Drug Administration on Thursday announced an aggressive agency-wide Artificial intelligence adoption timeline ...

WASHINGTON, D.C.—FDA Commissioner Martin Makary, M.D., offered more details into the agency’s recently announced plans to ...

The FDA is rolling out an aggressive plan to make generative AI a linchpin in its decision-making, part of a bid to get faster and leaner in evaluating drugs, foods, medical devices and diagnostic ...

Q1 2025 Management View CEO Panna Sharma stated that "the first quarter of 2025 represents a pivotal inflection point for ...

Dr Makary has directed all FDA centres to begin deployment immediately, with the goal of ‘full integration’ by the end of ...

The unintentional theme of today’s issue is the struggle for control over how we implement AI in the U.S. On one side, where ...

The Food and Drug Administration plans to rapidly roll out a generative AI model to assist scientific ... encourage careful testing before full adoption. The announcement spurred many questions.

The U.S. Food and Drug Administration (FDA) recently announced it plans to phase out animal testing in the development of monoclonal ...

Jeremy Walsh, who was recently named as the FDA's first-ever AI officer, has reportedly led the discussions with OpenAI, but so far, "no contract has been signed." 'Broader trend of AI adoption in ...